---

---

tags : Covid-19    symbols : GSK   

save search

---

Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| 17.03% | O: 1.91% H: 0.0% C: 0.0%
VERV | $6.715 0.83% 170K |

Professional, Scientific, and T...

| -63.96% | O: 0.37% H: 0.64% C: -10.76%
GSK | $39.565 0.75% 170K |

Health Technology

| 13.21% | O: 0.46% H: 0.46% C: -0.23%
MRNA S | $102.875 0.86% 440K |

Health Technology

| 40.43% | O: -0.01% H: 0.03% C: -3.14%
CVAC | News | $2.44 35K |

Health Technology

| -55.72% | O: 0.91% H: 1.08% C: -1.44%
BNTX | $86.43 0.3% 60K |

Health Technology

| -15.82% | O: 0.13% H: 0.08% C: -2.81%
ARCT 4 | $26.8 1.82% 44K |

Health Technology

| 34.35% | O: -0.36% H: 0.79% C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market

---

COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published: 2023-11-06 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| 17.51% | O: 0.41% H: 0.0% C: 0.0%
VTRS | $11.26 1.26% 500K |

Health Technology

| 20.74% | O: 0.11% H: 0.33% C: -0.98%
TEVA | $12.96 1.41% 1.6M |

Health Technology

| 45.64% | O: 0.22% H: 1.49% C: -0.33%
TAK | News | $13.235 0.57% 100K |

Health Technology

| -4.08% | O: 0.44% H: 0.22% C: 0.07%
NVS | $93.43 0.93% 220K |

Health Technology

| -0.4% | O: 0.24% H: 0.18% C: 0.16%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -4.43% | O: 0.18% H: 0.0% C: 0.0%
GSK | $39.565 0.75% 170K |

Health Technology

| 13.83% | O: 0.55% H: 0.3% C: 0.0%
ABT | News | $107.145 1.78% 1.3M |

Health Technology

| 11.32% | O: -0.42% H: 0.0% C: 0.0%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -0.36% | O: -1.32% H: 0.0% C: 0.0%
covid-19

---

CureVac meldet Fortschritte in klinischen Phase-2-Entwicklungsprogrammen für COVID-19 und die saisonale Grippe in Zusammenarbeit mit GSK
Published: 2023-11-01 (Crawled : 13:00) - curevac.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| 12.22% | O: -1.62% H: 0.0% C: 0.0%
GSK | $39.565 0.75% 170K |

Health Technology

| 10.92% | O: -4.06% H: 1.9% C: 0.96%
CVAC | News | $2.44 35K |

Health Technology

| -53.96% | O: 0.19% H: 3.95% C: -1.32%
covid-19 phase 2

---

CureVac veröffentlicht positive Daten bei älteren Erwachsenen aus COVID-19- und Grippe-mRNA-Impfstoffentwicklungsprogrammen
Published: 2023-01-30 (Crawled : 12:20) - curevac.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| 13.67% | O: -2.59% H: 3.12% C: 1.79%
GSK | $39.565 0.75% 170K |

Health Technology

| 12.18% | O: 0.74% H: 0.2% C: -1.24%
CVAC | News | $2.44 35K |

Health Technology

| -78.58% | O: 5.36% H: 4.0% C: -3.5%
covid-19 positive

---

CureVac gibt positive Daten aus gemeinsamen COVID-19- und Grippe-mRNA-Impfstoffentwicklungsprogrammen bekannt
Published: 2023-01-06 (Crawled : 12:20) - curevac.com
GSK | $39.565 0.75% 170K |

Health Technology

| 14.85% | O: -0.44% H: 1.85% C: 1.72%
CVAC | News | $2.44 35K |

Health Technology

| -61.76% | O: 12.7% H: 15.44% C: 14.88%
covid-19 positive

---

Global Pharmaceutical Packaging Market Report 2022-2027: Supply Chain Analysis, Technologies, Regulations, Future Trends, Impacts of COVID-19
Published: 2023-01-05 (Crawled : 12:20) - prnewswire.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| 15.03% | O: -1.77% H: 0.75% C: 0.75%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -19.53% | O: -0.62% H: 0.54% C: -0.12%
GSK | $39.565 0.75% 170K |

Health Technology

| 13.05% | O: -1.28% H: 0.35% C: -0.29%
AMCR | News | $8.97 0.79% 540K |

Process Industries

| -26.52% | O: -0.83% H: 0.59% C: -0.08%
covid-19 global report market

---

Gastrointestinal Drugs Market Research Report by Drug Category, Route of Administration, Disease Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-23 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| 12.85% | O: -3.13% H: 0.0% C: -0.23%
TAK | News | $13.235 0.57% 100K |

Health Technology

| -14.72% | O: 0.13% H: 0.71% C: 0.65%
GSK | $39.565 0.75% 170K |

Health Technology

| 12.15% | O: -0.14% H: 0.28% C: -0.11%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -5.35% | O: -0.23% H: 0.0% C: 0.0%
covid-19 drug research global disease report impact gastrointestinal market

---

Non-steroidal Anti-inflammatory Drugs Market Research Report by Disease Indication, Drugs, Route of Administration, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-07 (Crawled : 16:00) - prnewswire.com
RBGPF | $51.61 4.7K |

Consumer Non-Durables

| -26.52% | O: 0.06% H: 3.15% C: 0.15%
GLAXF | $20.2 0.65% 0 |

Health Technology

| 7.16% | O: 0.74% H: 0.0% C: -6.74%
SNYNF | News | $92.7 600K |

Health Technology

| -4.51% | O: 1.62% H: 0.0% C: -4.28%
AZNCF | $138.24 -1.36% 0 |

Health Technology

| -1.06% | O: -0.56% H: 0.61% C: 0.01%
RBGLY | $10.35 990K |

Manufacturing

| -29.45% | O: 0.51% H: 0.48% C: -0.14%
VTRS | $11.26 1.26% 500K |

Health Technology

| 1.74% | O: 0.0% H: 0.55% C: -0.27%
ZTS | News | $149.195 -2.56% 620K |

Health Technology

| -1.08% | O: -0.06% H: 0.54% C: -1.77%
PRGO | $30.16 0.74% 97K |

Health Technology

| -5.33% | O: -0.09% H: 0.47% C: -0.28%
GSK | $39.565 0.75% 170K |

Health Technology

| 4.43% | O: -0.98% H: 0.24% C: -1.78%
LLY | $745.04 -0.12% 410K |

Health Technology

| 103.71% | O: 0.21% H: 1.6% C: 0.72%
SNY | News | $46.135 1.64% 270K |

Health Technology

| 0.86% | O: 5.18% H: 0.0% C: 0.0%
AZN | $68.505 0.21% 580K |

Health Technology

| -0.43% | O: 0.45% H: 0.64% C: -0.03%
covid-19 research global disease report impact distribution market

---

Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| 29.9% | O: -0.06% H: 0.0% C: 0.0%
AZNCF | $138.24 -1.36% 0 |

Health Technology

| 12.29% | O: 6.22% H: 3.13% C: -0.56%
NVS | $93.43 0.93% 220K |

Health Technology

| 12.19% | O: 2.81% H: 0.43% C: -0.2%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -16.77% | O: 0.18% H: 0.0% C: 0.0%
GSK | $39.565 0.75% 170K |

Health Technology

| 22.15% | O: 2.59% H: 0.72% C: 0.63%
BMY | $48.295 -0.01% 920K |

Health Technology

| -39.46% | O: 1.22% H: 0.01% C: -1.7%
IOVA M | $11.42 -2.56% 780K |

Health Technology

| 50.51% | O: 6.12% H: 4.99% C: 4.21%
INO 3 d | $9.98 -2.16% 50K |

Health Technology

| 367.89% | O: 5.5% H: 4.35% C: 3.48%
GILD | News | $66.52 0.54% 780K |

Health Technology

| -18.73% | O: 1.43% H: 0.36% C: -1.08%
ATRA | $0.687 -0.68% 180K |

Health Technology

| -82.43% | O: 2.58% H: 23.12% C: 20.85%
AZN | $68.505 0.21% 580K |

Health Technology

| 11.82% | O: 7.08% H: 0.84% C: -0.43%
ADAP | $1.01 12.42% 540K |

Health Technology

| -50.95% | O: 0.0% H: 7.14% C: 5.71%
covid-19 research global immunotherapy report impact technology market

---

CureVac beginnt mit klinischer Phase 1-Studie für modifizierten COVID-19-Impfstoffkandidaten gegen Omikron-Variante
Published: 2022-08-18 (Crawled : 12:00) - curevac.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| 22.0% | O: -3.07% H: 9.03% C: 4.86%
GSK | $39.565 0.75% 170K |

Health Technology

| 14.12% | O: -0.32% H: 0.03% C: -0.98%
CVAC | News | $2.44 35K |

Health Technology

| -81.49% | O: -0.61% H: 1.64% C: -4.58%
covid-19 phase 1

---

The Gynecology Drugs Market Is To Reach $26 Bn As It Recovers From The COVID-19 Impact
Published: 2022-05-04 (Crawled : 15:20) - prnewswire.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| -27.21% | O: -1.58% H: 0.0% C: 0.0%
AZNCF | $138.24 -1.36% 0 |

Health Technology

| 4.02% | O: 3.26% H: 0.0% C: -3.77%
PKX | News | $70.68 0.83% 9.6K |

Non-Energy Minerals

| 23.3% | O: 0.38% H: 2.4% C: 2.4%
GSK | $39.565 0.75% 170K |

Health Technology

| -12.23% | O: -0.2% H: 0.0% C: 0.0%
AZN | $68.505 0.21% 580K |

Health Technology

| 1.63% | O: -0.79% H: 0.0% C: 0.0%
AMGN | $263.65 0.34% 360K |

Health Technology

| 13.81% | O: -0.09% H: 1.95% C: 1.52%
covid-19 market drug

---

GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19
Published: 2022-01-13 (Crawled : 15:30) - biospace.com/
SNYNF | News | $92.7 600K |

Health Technology

| -11.65% | O: 0.0% H: 0.0% C: 0.0%
GSK | $39.565 0.75% 170K |

Health Technology

| -12.62% | O: 0.29% H: 0.0% C: 0.0%
XNCR | $18.57 -2.01% 83K |

Health Technology

| -47.68% | O: 0.38% H: 1.12% C: -1.31%
VIR | $8.095 1.7% 58K |

Health Technology

| -79.38% | O: 1.05% H: 1.98% C: -6.88%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -11.46% | O: -0.74% H: 0.0% C: 0.0%
covid-19 treatment fda application covid authorization merge emergency use authorization

---

Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19
Published: 2021-12-17 (Crawled : 13:30) - globenewswire.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| -4.72% | O: 2.36% H: 0.46% C: 0.46%
SNYNF | News | $92.7 600K |

Health Technology

| -3.77% | O: -0.48% H: 0.0% C: 0.0%
GSK | $39.565 0.75% 170K |

Health Technology

| -8.4% | O: 0.86% H: 0.0% C: 0.0%
XNCR | $18.57 -2.01% 83K |

Health Technology

| -47.87% | O: -0.45% H: 0.0% C: 0.0%
VIR | $8.095 1.7% 58K |

Health Technology

| -85.14% | O: -4.59% H: 0.0% C: 0.0%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -7.59% | O: 0.22% H: 0.0% C: 0.0%
covid-19 treatment europe granted covid authorization grant

---

GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment
Published: 2021-11-17 (Crawled : 12:00) - globenewswire.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| -2.23% | O: 1.43% H: 2.31% C: 2.27%
GSK | $39.565 0.75% 170K |

Health Technology

| -6.54% | O: -0.28% H: 0.0% C: 0.0%
VIR | $8.095 1.7% 58K |

Health Technology

| -74.73% | O: 9.97% H: 4.0% C: -6.28%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -11.13% | O: -0.06% H: 0.0% C: 0.0%
covid treatment biotech technology iot covid-19

---

CureVac verlagert Fokus der COVID-19-Impfstoffentwicklung auf mRNA-Technologie der zweiten Generation
Published: 2021-10-12 (Crawled : 12:00) - curevac.com
GLAXF | $20.2 0.65% 0 |

Health Technology

| 3.59% | O: 3.38% H: 0.0% C: -5.75%
GSK | $39.565 0.75% 170K |

Health Technology

| 3.56% | O: 2.51% H: 0.15% C: -1.43%
CVAC | News | $2.44 35K |

Health Technology

| -94.35% | O: -13.04% H: 13.08% C: 9.7%
covid covid-19

---

Cardiovascular Devices Market Witnesses Neutral Impact with Growth Worth $ 32.06 Billion due to COVID-19 | Technavio
Published: 2021-09-17 (Crawled : 10:00) - prnewswire.com
GSK | $39.565 0.75% 170K |

Health Technology

| 1.25% | O: -0.41% H: 0.0% C: 0.0%
covid cardiovascular growth device cardio covid-19

---

High Virus Count in the Lungs Drives Covid-19 Deaths
Published: 2021-08-31 (Crawled : 09:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -16.53% | O: -0.1% H: 0.58% C: -0.21%
GSK | $39.565 0.75% 170K |

Health Technology

| -3.2% | O: -0.61% H: 0.52% C: 0.2%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -11.97% | O: 0.02% H: 0.4% C: 0.14%
covid lungs covid-19

---

Biologics Global Market Report 2021: COVID-19 Impact and Recovery to 2030
Published: 2021-08-17 (Crawled : 22:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -19.23% | O: 0.02% H: 0.0% C: -1.29%
GSK | $39.565 0.75% 170K |

Health Technology

| -6.45% | O: 0.17% H: 0.66% C: -0.59%
covid covid-19

---

GSK and Vir Biotechnology Announce Joint Procurement Agreement with European Commission for COVID-19 Treatment, Sotrovimab
Published: 2021-07-28 (Crawled : 12:00) - biospace.com/
GSK | $39.565 0.75% 170K |

Health Technology

| 0.2% | O: -1.06% H: 1.31% C: 1.02%
VIR | $8.095 1.7% 58K |

Health Technology

| -77.36% | O: 1.54% H: 4.68% C: 0.14%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -11.8% | O: -0.5% H: 1.7% C: 1.4%
covid treatment europe biotech technology iot covid-19

---

North America Preventive Vaccines Market: COVID-19 Impact and Growth Opportunity 2021-2026
Published: 2021-06-11 (Crawled : 20:00) - prnewswire.com
NVAX | $3.97 2.06% 400K |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.135 1.64% 270K |

Health Technology

| Email alert Add to watchlist
AZN | $68.505 0.21% 580K |

Health Technology

| Email alert Add to watchlist
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| Email alert Add to watchlist
GSK | $39.565 0.75% 170K |

Health Technology

| Email alert Add to watchlist
covid vaccine growth covid-19

---

Gainers vs Losers

82%

18%

Top 10 Gainers

AGBA | News | $1.37 242.5% 76M |

Finance

EGOX | $0.0835 131.94% 160M |

ZCMD | $2.18 50.35% 24M |

Commercial Services

CHRO | $1.73 41.22% 46K |

n/a

RWOD | $10.61 32.68% 5.1M |

n/a

NVFY | $2.77 31.28% 2.2M |

Consumer Durables

AULT | $0.3174 31.1% 28M |

Manufacturing

WISA 4 | $7.11 20.71% 4.7M |

Electronic Technology

LIFW | News | $0.99 19.26% 800K |

Administrative and Support and ...

PRTG | $0.285 18.75% 140K |

Mining, Quarrying, and Oil and ...

---

Your saved searches

---